Govt disburses ₹36,754 crore under PLI schemes till June 30
The government has disbursed ₹36,754 crore in cumulative incentives to companies under various Production Linked Incentive (PLI) schemes, as on 30 June 2026.
These schemes have collectively generated employment of over 14.57 lakh (direct and indirect) jobs so far.
Cumulative investment recorded under PLI schemes stands at ₹2.58 lakh crore, against which production/sales worth ₹23.79 lakh crore and exports worth ₹15.53 lakh crore have been achieved.
Sector-specific outcomes cited include the domestic manufacture of 1,931 pharmaceutical products — including 191 bulk drugs manufactured in India for the first time — and investments exceeding ₹19,000 crore in the specialty steel sector.
PLI Scheme — Fiscal Design and Why "Disbursement" Lags "Outlay"
The Production Linked Incentive (PLI) scheme, launched by the Union Cabinet in November 2020 across 14 strategic sectors with a total outlay of ₹1.97 lakh crore, is structured as a performance-linked subsidy rather than an upfront capital grant or tax holiday (unlike earlier industrial incentive instruments such as Special Economic Zone tax benefits). Companies must first invest and achieve verified incremental production/sales over a base year before they can claim the incentive, which is why actual cash disbursed at any point in time is typically much smaller than the scheme's total budgeted outlay.
Key Details
- Total PLI outlay (ceiling across 14 sectors): ₹1.97 lakh crore, launched November 2020
- Incentive rate: typically 4–6% of incremental sales over a base year, varying by sector
- Disbursement occurs only after claims are verified against actual (not projected) production/sales performance
- As a result, "outlay" (₹1.97 lakh crore budgeted) and "disbursed" (₹36,754 crore actually paid out) are not the same figure and should not be conflated
The ₹36,754 crore figure represents actual verified cash payouts against the ₹1.97 lakh crore ceiling, indicating the scheme remains in a multi-year ramp-up/disbursement phase rather than being exhausted.
DPIIT's Role in Monitoring PLI Performance
The Department for Promotion of Industry and Internal Trade (DPIIT), under the Ministry of Commerce and Industry, coordinates and monitors PLI implementation across sector-specific nodal ministries — for example, the Department of Pharmaceuticals for the pharma/medical devices PLIs and the Ministry of Steel for the specialty steel PLI — and periodically consolidates scheme-wide investment, production, export, employment and disbursement data.
Key Details
- DPIIT was constituted in 2019 by renaming and re-designating the erstwhile Department of Industrial Policy and Promotion (DIPP)
- Each sectoral PLI scheme has its own nodal ministry and a Project Management Agency (PMA) responsible for claim verification before disbursement
- Consolidated national-level figures (like the ₹36,754 crore cumulative disbursement) are released periodically by DPIIT/the Commerce and Industry Ministry
The aggregated figures cited — disbursement, investment, production, exports and employment — are exactly the kind of scheme-wide monitoring data DPIIT is tasked with compiling and releasing.
Reading PLI Performance Metrics — Outlay, Investment, Production and Disbursement Are Distinct
PLI performance is commonly reported using several distinct and non-interchangeable metrics: (a) the scheme's total budgeted outlay/ceiling; (b) actual investment made by beneficiary companies; (c) production/sales value achieved; (d) export value generated; and (e) cumulative incentive disbursed by the government. A useful pattern for students: investment leveraged (₹2.58 lakh crore) is already well above the fiscal outlay (₹1.97 lakh crore), illustrating the "multiplier" rationale often cited for PLI as an industrial policy tool — a relatively modest fiscal commitment inducing a much larger quantum of private investment, production and exports.
Key Details (as on 30 June 2026): - Actual investment: ₹2.58 lakh crore - Production/sales recorded: ₹23.79 lakh crore - Exports recorded: ₹15.53 lakh crore - Employment generated (direct + indirect): over 14.57 lakh - Cumulative incentive disbursed: ₹36,754 crore
Distinguishing these metrics prevents a common error of treating any single large rupee figure quoted in PLI news as the "cost" of the scheme to the exchequer — only the disbursement figure represents actual fiscal outgo.
Sector Illustrations — Pharmaceuticals and Specialty Steel
Beyond the aggregate national figures, sector-specific outcomes are frequently cited as illustrative data points: domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs (APIs) manufactured in India for the first time under the PLI framework; and investment exceeding ₹19,000 crore by major producers in the specialty steel sector.
Key Details
- Pharmaceuticals: 1,931 products now manufactured domestically; 191 bulk drugs manufactured in India for the first time
- Specialty steel: over ₹19,000 crore invested by leading domestic steel producers under the sector's PLI scheme
These sector-level figures are the kind of specific data points likely to be tested alongside the aggregate national disbursement figures in objective-type questions on PLI outcomes.
- Cumulative PLI incentive disbursed (as on 30 June 2026): ₹36,754 crore
- Employment generated: over 14.57 lakh (direct + indirect)
- Cumulative investment recorded: ₹2.58 lakh crore
- Production/sales recorded: ₹23.79 lakh crore
- Exports recorded: ₹15.53 lakh crore
- Total PLI outlay/ceiling (14 sectors, launched November 2020): ₹1.97 lakh crore
- Pharmaceuticals sector: 1,931 products manufactured domestically, including 191 bulk drugs made in India for the first time
- Specialty steel sector: over ₹19,000 crore invested by major producers
- Nodal coordinating authority: DPIIT, Ministry of Commerce and Industry